EpiBiologics
Company

EpiBiologics

Biotechnology Research San Mateo, California, United States 41 employees
Employees
41
Contacts
3
Emails
3
Phones
1

EpiBiologics Overview

Headquarters
San Mateo, California, United States
Industry
Biotechnology Research
Employees
41
Funding
23.0M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
62

About EpiBiologics

EpiBiologics is building a next-generation protein degradation platform that targets membrane and extracellular proteins. EpiBiologics was founded in 2022 based on the pioneering work from academic founder Dr. Jim Wells of the University of California San Francisco (UCSF). The Company’s proprietary EpiTAC platform is a modular antibody-based system that enables the precise degradation of disease-driving membrane and extracellular proteins in a tissue-specific manner. Headquartered in San Mateo, EpiBiologics is backed by leading healthcare investors and aims to develop first-in-class and best-in-class targeted therapies across multiple therapeutic areas. For more information, please visit epibiologics.com and follow us on LinkedIn.

EpiBiologics Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
1
25.0% coverage

EpiBiologics Org Chart

Sample employees and titles
Name Title Contact
Lisa Marshall
Email
Isaac J. Rondon
Email
Aaron Mishel Finance Executive - Healthcare / Life Sciences
View
Ken Flanagan
Email Phone

Compare Similar Companies to EpiBiologics